Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 5, 2026

May 5, 2026

Naples Therapeutic Riding Center Celebrates Record-Setting Kentucky Derby Party

Indeterminate EIN Presswire

May 5, 2026

Free Life Insurance Policy Valuation Service Launches for Seniors During Older Americans Month

Indeterminate EIN Presswire

May 5, 2026

Joe Binley, Founder of ProjectAD, Integrates Protein Signaling in New Book 'Mastering Metabolism'

Indeterminate EIN Presswire

May 5, 2026

ASTR Institute Highlights Four-Day Intensive for Complex Chronic Pain

Indeterminate EIN Presswire

May 5, 2026

Scott R. Storick Appointed Trustee of Boca Raton Chamber of Commerce

Indeterminate EIN Presswire

May 5, 2026

AB Global Names Don Darrah Chief Growth Officer to Lead Unified Growth Strategy

Indeterminate EIN Presswire

May 5, 2026

ISOThrive Reports Highly Statistically Significant Phase 2 Data for MHS-1031 in NERD Patients at DDW 2026

Indeterminate GlobeNewswire

May 5, 2026

Mystic Force Foundation Celebrates 18 Years of Impact & 8 Years of Heroes Hangout, a Magical Childhood Cancer Haven

Indeterminate EIN Presswire

May 5, 2026

Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions

Indeterminate GlobeNewswire

May 5, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 5, 2026

EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction

Indeterminate GlobeNewswire

May 5, 2026

Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

May 5, 2026

STERIS Announces Dividend of $0.63 per share

Indeterminate GlobeNewswire

May 5, 2026

Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results

Indeterminate GlobeNewswire

May 5, 2026

FDA Expands Market Access, Authorizes New ENDS Products

Indeterminate GlobeNewswire

May 5, 2026

Pacira BioSciences Mails Letter to Stockholders

Indeterminate GlobeNewswire

May 5, 2026

Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026

Indeterminate GlobeNewswire

May 5, 2026

Sienna Reports First Quarter 2026 Financial Results and Continues Platform Expansion

Indeterminate GlobeNewswire

May 5, 2026

Cytokinetics Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

May 5, 2026

OnKure Therapeutics Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire